The global Microtome market is expected to develop USD 73.5 Million by 2030, at a compound annual increase in price (CAGR) of 5.21% throughout the forecast period.
The global microtome market was valued at USD 107.5 million in 2019. Increase in prevalence of chronic diseases such as cancer, surging demand for digital pathology, growing geriatric population coupled with increasing healthcare spending are key factors driving the global microtome market.
Microtome are devices that are used to slice biological sensor specimens into evenly thin sections for a detailed microscopic examination. These are used in a range of settings including clinic al virtual science laboratories, hospitals and research institutes. Various types of microtome are available in the market including rotating, cryostat/freezing, sliding, and laser microtomes. Increase in prevalence of cancer across the globe along with increase in healthcare expenditure especially in developed economies are major factors propelling the growth of the market. Furthermore, rise in geriatric population fuels the need for early diagnosis and treatment of chronic diseases. This has led to increased demand for microtomes. Moreover, advantages offered by microtomes in histopathology practices is expected to drive the global market. Some of the microtome products available in the market include Cryostat Microtome SMI-3010, Semi-Automatic Rotary Microtome M530, CUT 4062 manual microtome and CR-X Cryo System.
The global microtome market has been segmented based on product, application, technology, end-users, and region. Based on product, the global microtome market is categorized into instruments and accessories. In 2019, instruments segment held dominant share of the global market. By application, the global microtome market is segmented into medical research and disease diagnosis. Geographically, North America dominated the global microtome market in 2019, however, Asia Pacific is expected to be the fastest growing region by 2028.
Key players operating in the global microtome market are Leica Biosystems Nussloch GmbH, Sakura Finetek Europe B.V., Danaher Corporation, S.M. Scientific Instruments Pvt. Ltd., LLS ROWIAK LaserLabSolutions GmbH, MEDITE GmbH, Thermo Fischer Scientific, Amos Scientific Pty Ltd., SLEE Medical GmbH, and Boeckeler Instruments among others.
Microtome Market Scope
Metrics | Details |
Base Year | 2023 |
Historic Data | 2018-2022 |
Forecast Period | 2024-2030 |
Study Period | 2018-2030 |
Forecast Unit | Value (USD) |
Revenue forecast in 2030 | USD 73.5 Million |
Growth Rate | CAGR of 5.21% during 2020-2030 |
Segment Covered | By Product, Regions |
Regions Covered | North America, Europe, Asia Pacific, South America, Middle East and Africa |
Key Players Profiled | Abbott (US), Merck (Germany), Thermo Fisher (US), Danaher (US), Roche (Switzerland), Diasorin (Italy), Biomérieux (France), Diagnostic Automation/Cortez Diagnostics (US), Qualigen (US), Kronus (US), Autobio Diagnostics (China) |
Key Segment Of The Microtome Market
By Product (USD Million)
• Instruments
• Microtome Accessories
Technology (USD Million)
• Manual
• Semi Automated Microtomes
• Fully Automated Microtomes
Application (USD Million)
• Disease Diagnosis
• Medical Research
End User (USD Million)
• Hospital Laboratories
• Clinical Laboratories
Regional Overview (USD Million)
North America
• US
• Canada
Europe
• Germany
• France
• UK
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
South America
• Mexico
• Brazil
• Rest of South America
Middle East and South Africa
Frequently Asked Questions (FAQ) :
Microtome devices are used for biological sectioning that uses raisins or paraffin. Wide range application of microtome instruments and accessories in the field of regenerative medicine, cardiology, cardiovascular research and medicine, osteology and orthopedics is expected to surge its demand in the coming few years. The development of advanced instruments such as laser microtomes will offer immense growth opportunities. Laser microtome cuts the tissue through usage of photons and laser beams. For instance, LLS ROWIAK LaserLabSolutions GmbH offers laser microtome TissueSurgeon. It is multi-purpose sectioning instrument which enables precise and contact free cutting of biological samples and a wide range of biomaterials. Furthermore, TissueSurgeon is based on femto-second laser technology, which is used for sectioning, structuring or gentle extraction of samples and materials in 2D and 3D for analysis.
The global microtome market has been segmented based on product, application, technology, end-users, and region. Based on product, the global microtome market is categorized into instruments and accessories. Instruments segment is further sub-categorized into rotary microtome, cryostat microtome, vibrating microtome, and others. Instruments segment grabbed majority of the global microtome market in 2019. Easy availability and wide adoption of rotary microtomes in histology laboratories for cutting serial sections is expected to drive the growth of the segment. Application-wise, the global microtome is segmented into medical research and disease diagnosis. In 2019, disease diagnosis segment grabbed majority of the share of the global market owing to rise in incidence of cancer and other chronic diseases across the globe.
On the basis of technology, the global microtome market is segregated into manual, semi-automated and fully automated microtomes. Fully automated microtomes segment is anticipated to grow at a rapid pace owing to its ability to obtain high quality slicing using motorized push button sectioning process. Fully automated devices eliminate complexities, removes heat from specimen and provides slices as per the requirement. Furthermore, increasing preference for the digitalization of tissue diagnostic procedures is likely to propel the growth of the segment. On the basis of end-users, the global microtome market is segmented into hospitals, clinical laboratories and others. Clinical laboratories grabbed substantial share of the market share in 2019.
The global microtome market is cumulative to North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global microtome market in 2019, however Asia Pacific is expected to grow at a highest pace through 2028.
Rapid adoption of advanced cancer diagnostic and screening tests, increase in incidences of chronic diseases, favorable reimbursement scenario for anatomic pathology diagnostic tests in the U.S. and Canada are factors anticipated to drive the microtome market in the region. Moreover, easy accessibility to advanced technologies and increasing healthcare expenditure are other major factors likely to boost the growth of the market in North America.
However, Asia Pacific is expected to grow at a rapid pace over the next few years. There is a strong growth potential in the emerging economies such as India, and China. Increased cases of cancer and large geriatric patient pool in low- and middle-income countries is expected to create huge growth opportunities for market players to tap these regions which will eventually foster the demand for microtome in the future.